Results: There was a statistically significant difference between 6-MV and 10-MV with respect to the sum lung dose, which favored 6-MV plans (p=0.04). For those stratified by TCW, there was a difference in conformity index for patients with peripheral tumors (p=0.04). For the group stratified by AP separation, there was a difference in mean sum lung dose favoring 6-MV (p=0.01). In the group stratified by equivalent sphere diameter, there were statistically significant (SS) differences in lung V13, mean sum lung dose, and conformity index, all favoring 6-MV plans (p=0.05, p<0.01, and p<0.01). For the cohort overall, and within each subgroup, there was a SS difference in the total number of MUs, which consistently favored planning with 10-MV.
Conclusions: With the exception of thinner patients, for which 6-MV plans was superior with respect to OARs and conformity index, 10-MV should be considered for use in lung VMAT SBRT. 10-MV plans consistently resulted in fewer total MUs. Fewer MUs results in shorter treatment times, with the potential for improved target accuracy due to less intrafractional tumor motion.
